These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35436364)

  • 41. Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.
    Gallwitz B; Dagogo-Jack S; Thieu V; Garcia-Perez LE; Pavo I; Yu M; Robertson KE; Zhang N; Giorgino F
    Diabetes Obes Metab; 2018 Feb; 20(2):409-418. PubMed ID: 28817231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycaemic load versus carbohydrate counting for insulin bolus calculation in patients with type 1 diabetes on insulin pump.
    Bozzetto L; Giorgini M; Alderisio A; Costagliola L; Giacco A; Riccardi G; Rivellese AA; Annuzzi G
    Acta Diabetol; 2015 Oct; 52(5):865-71. PubMed ID: 25697600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can an electronic glycaemic notebook associated with an insulin calculator improve HbA1c in diabetic patients on a multiple insulin injections regimen? A 26-week observational real-life study.
    Oriot P; Ponchon M; Hermans MP
    Acta Clin Belg; 2016 Feb; 71(1):51-6. PubMed ID: 27150670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial.
    Griauzde DH; O'Brien A; Yancy WS; Richardson CR; Krinock J; DeJonckheere M; Isaman DJM; Vanias K; Shopinski S; Saslow LR
    Trials; 2022 Sep; 23(1):827. PubMed ID: 36176003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-carbohydrate dietary pattern on glycemic outcomes trial (ADEPT) among individuals with elevated hemoglobin A1c: study protocol for a randomized controlled trial.
    Dorans KS; Bazzano LA; Qi L; He H; Appel LJ; Samet JM; Chen J; Mills KT; Nguyen BT; O'Brien MJ; Uwaifo GI; He J
    Trials; 2021 Feb; 22(1):108. PubMed ID: 33522954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
    Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A
    BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictor factors of glycemic control in children and adolescents with type 1 diabetes mellitus treated at a referral service in Rio de Janeiro, Brazil.
    Fortins RF; Lacerda EMA; Silverio RNC; do Carmo CN; Ferreira AA; Felizardo C; do Nascimento BF; Luescher JL; Padilha PC
    Diabetes Res Clin Pract; 2019 Aug; 154():138-145. PubMed ID: 31150723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double-blind, phase 3 trial.
    Kaku K; Isaka H; Sakatani T; Toyoshima J
    Diabetes Obes Metab; 2019 Oct; 21(10):2284-2293. PubMed ID: 31173455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of a low-carbohydrate diet in adults with type 1 diabetes management: A single arm non-randomised clinical trial.
    Turton JL; Brinkworth GD; Parker HM; Lim D; Lee K; Rush A; Johnson R; Rooney KB
    PLoS One; 2023; 18(7):e0288440. PubMed ID: 37432920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
    Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
    BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different types of dietary advice for women with gestational diabetes mellitus.
    Han S; Crowther CA; Middleton P; Heatley E
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009275. PubMed ID: 23543574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials.
    Godoi A; Reis Marques I; Padrão EMH; Mahesh A; Hespanhol LC; Riceto Loyola Júnior JE; de Souza IAF; Moreira VCS; Silva CH; Miyawaki IA; Oommen C; Gomes C; Silva AC; Advani K; de Sa JR
    Diabetol Metab Syndr; 2023 Sep; 15(1):190. PubMed ID: 37759290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.